Selected article for: "acute respiratory ards distress syndrome and lung tissue"

Author: Birnhuber, Anna; Fliesser, Elisabeth; Gorkiewicz, Gregor; Zacharias, Martin; Seeliger, Benjamin; David, Sascha; Welte, Tobias; Schmidt, Julius; Olschewski, Horst; Wygrecka, Malgorzata; Kwapiszewska, Grazyna
Title: Between inflammation and thrombosis – endothelial cells in COVID-19
  • Cord-id: xaz1ee50
  • Document date: 2021_5_6
  • ID: xaz1ee50
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current coronavirus disease (COVID-19) pandemic [1]. Over the last months, a plethora of novel research articles has been published, dealing with multiple aspects and manifestations of the disease. Increasing evidence points to a central role of endothelial cells (ECs) in SARS-CoV-2 infection [2–5]. Early studies have already indicated increased expression of vascular and inflammatory factors (such as VCAM-1, IL-8 or M
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current coronavirus disease (COVID-19) pandemic [1]. Over the last months, a plethora of novel research articles has been published, dealing with multiple aspects and manifestations of the disease. Increasing evidence points to a central role of endothelial cells (ECs) in SARS-CoV-2 infection [2–5]. Early studies have already indicated increased expression of vascular and inflammatory factors (such as VCAM-1, IL-8 or MCP-1) in COVID-19 lung tissue [2]. Such markers of endothelial dysfunction and altered endothelial cell integrity are important predictors of a poor outcome in SARS-CoV-2 infections [6], and they are associated with pulmonary edema, intravascular thrombosis and acute respiratory distress syndrome (ARDS).

    Search related documents:
    Co phrase search for related documents